NCT07507227

Brief Summary

Peripheral nerve blocks are increasingly used in lower extremity surgery as an alternative to general anesthesia. However, traditional methods used to assess block success, such as sensory and motor testing, are subjective, time-consuming, and dependent on patient cooperation. The perfusion index (PI), measured non-invasively using pulse oximetry, reflects peripheral perfusion changes associated with sympathetic blockade and may serve as an early indicator of block effectiveness. This study aims to evaluate whether PI can be used as an early and reliable marker for assessing the success of combined femoral and sciatic nerve block in patients undergoing elective lower extremity surgery. A total of 80 patients aged 18-65 years with ASA physical status I-III will receive ultrasound- and nerve stimulator-guided combined femoral and sciatic nerve block. Hemodynamic parameters and perfusion-related variables, including PI, capillary refill time, and skin temperature, will be recorded at baseline and at 5, 10, 20, and 30 minutes after block administration. The results will be compared with traditional sensory and motor block assessments to determine whether PI provides an earlier and objective assessment of block success.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2019

Completed
7.2 years until next milestone

First Submitted

Initial submission to the registry

March 27, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 2, 2026

Completed
Last Updated

April 2, 2026

Status Verified

March 1, 2026

Enrollment Period

3 months

First QC Date

March 27, 2026

Last Update Submit

March 27, 2026

Conditions

Keywords

Perfusion IndexFemoral Nerve BlockSciatic Nerve BlockPeripheral Nerve BlockRegional Anesthesia

Outcome Measures

Primary Outcomes (1)

  • Change in Perfusion Index Following Nerve Block

    Perfusion index values measured at predefined time intervals after combined femoral and sciatic nerve block and compared with baseline and contralateral limb values.

    Baseline, 5, 10, 20, and 30 minutes after block administration

Study Arms (1)

Combined Femoral and Sciatic Nerve Block

EXPERIMENTAL

All participants receive ultrasound- and nerve stimulator-guided combined femoral and sciatic nerve block prior to lower extremity surgery.

Procedure: Combined Femoral and Sciatic Nerve Block

Interventions

Ultrasound- and nerve stimulator-guided femoral and sciatic nerve block performed using a mixture of bupivacaine and lidocaine for anesthesia in lower extremity surgery.

Combined Femoral and Sciatic Nerve Block

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged between 18 and 65 years
  • ASA physical status I-III
  • Scheduled for elective lower extremity surgery
  • Patients undergoing combined femoral and sciatic nerve block
  • Ability to provide informed consent

You may not qualify if:

  • Patient refusal
  • Infection at the injection site
  • Known allergy to local anesthetic agents
  • Coagulopathy or bleeding disorders
  • Pre-existing neurological deficits in the lower extremities
  • Severe systemic disease (ASA IV and above)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gaziantep University Faculty of Medicine

Gaziantep, Turkey (Türkiye)

Location

Study Officials

  • Berna Kaya Uğur

    Gaziantep University Faculty of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: This is a single-group interventional study in which all participants receive combined femoral and sciatic nerve block. Perfusion index and conventional block assessment methods are measured and compared over time to evaluate block success.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 27, 2026

First Posted

April 2, 2026

Study Start

June 1, 2018

Primary Completion

September 1, 2018

Study Completion

January 31, 2019

Last Updated

April 2, 2026

Record last verified: 2026-03

Locations